FluMist Live Virus Persistence: Duration and Immunological Role
FluMist (live attenuated influenza vaccine, LAIV) contains temperature-sensitive, cold-adapted strains that replicate in the cooler nasopharynx (33–34°C) but not lower respiratory tract (37°C).
Persistence Timeline
- Detection window: Vaccine virus recoverable from nasal swabs for 3–14 days post-administration (peak days 2–5).
- Clearance: Typically complete by 2 weeks; rarely up to 28 days in young children.
- Shedding: Vaccinees can shed virus—caution around severely immunocompromised contacts for 7 days.
Immunological Purpose
Limited replication mimics natural infection, inducing:
- Mucosal IgA (nasal, salivary) → blocks viral entry.
- Systemic IgG (hemagglutination inhibition antibodies).
- Cell-mediated immunity (CD8+ T cells) → cross-protective against drifted strains.
Contraindications
- Immunocompromised patients and close contacts.
- Pregnancy.
- Age <2 or >49 years (per FDA labeling).
- Asthma/wheezing in children 2–4 years.
Consult CDC/ACIP guidelines for current recommendations.
Viral Infections - Related Articles
- Understanding the Flu Virus: A 12-Day Life Cycle
- Ebola Virus Disease: Symptoms, Transmission, and Management
- Understanding Life Expectancy with Hepatitis C
- Swine Flu Vaccine: Side Effects, Symptoms & What to Expect
- Monkey B Virus (Herpes B): Transmission, Symptoms, and Prevention
- Norforms and Bacterial Vaginosis: Why They Don't Mix
- Respiratory Virus Symptoms: Signs, Prevention & Information
